
IBB vs IBBQ
Two funds, one decision: we compare cost, performance and what each ETF actually holds in October 2026.
Compare iShares Biotechnology ETF (IBB) and Invesco Nasdaq Biotechnology ETF (IBBQ). This page reviews expenses, net assets, dividend yields, inception dates, and top holdings. Note that index tracking details are not available for either fund. Educational content, not financial advice.
Compare iShares Biotechnology ETF (IBB) and Invesco Nasdaq Biotechnology ETF (IBBQ). This page reviews expenses, net assets, dividend yields, inception dates, and top holdings. Note that index trackin...
Investment Analysis

IBB
IBB
Pros
- IBB offers extensive liquidity given its substantial net assets exceeding ten billion dollars.
- It provides long operational history, having been established in February 2001.
- The fund features a diverse top ten portfolio spanning established biopharmaceutical companies.
Considerations
- Its expense ratio of 0.44 percent is significantly higher than alternative options.
- The dividend yield of 0.16 percent remains low compared to peer funds.
- Concentrated top holdings like Gilead and Vertex increase single-stock risk exposure.
IBBQ
IBBQ
Pros
- IBBQ benefits from a lower expense ratio of 0.19 percent versus competitors.
- Its dividend yield of 0.74 percent offers better income potential than IBB.
- The fund maintains a similar top ten holding structure to its larger rival.
Considerations
- With only ninety-six million dollars in net assets, liquidity may be limited.
- Inception in June 2021 means it lacks the long track record of IBB.
- It does not disclose index tracking details, limiting transparency for investors.
Buy IBB or IBBQ in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.

